Home
- Eating Well (or at Least Not terribly) at Fast Food Resturants
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Related Community Videos on Diabetes Health TV
Popular Type 2 Diabetes Articles
Highly Recommended Type 2 Diabetes Articles
Type 2 Diabetes
Page 2
We’ve all heard a lot of discussion about low carbohydrate diets and whether they are effective for weight loss and blood sugar control.. What most of us do not understand, however, is how diabetes affects the way that we process carbs. Beta cells make more than insulin: they also make another satiety hormone: amylin. If we are beta-cell deficient, then we are amylin-deficient as well. When the amylin hormone is not available to tell our brain that we are full, we crave more food, especially carbohydrates. Carbohydrates act as a mood stabilizer, making us feel good when we’re stressed.
1 comment - Aug 31, 2012 -
Older type 2s who exercise tight control over their blood sugar may run an increased risk of hip fracture, says a study from Changi General Hospital in Singapore. The researchers studied 558 elderly people with diabetes who had been treated for hip fracture between 2005 and 2010. They found that those patients had a significantly lower median A1C, 6.8%, than the control group median of 7.4%. In 59.2 percent of the hip fracture cases, the patient's A1C was less than 7%, and slightly more than three-quarters of the patients were taking sulfonylureas.
1 comment - Aug 30, 2012 -
The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type 2 diabetes. Actos, originally developed and trademarked by Takeda Pharmaceuticals, works by decreasing insulin resistance in type 2 patients. The prescription drug, which belongs to the class of drugs known as thiazolidinediones (TZDs), has enjoyed great commercial success in the United States since its introduction in 1999, posting estimated sales last year of $2.7 billion.
0 comments - Aug 27, 2012 -
As diabetes climbs to epidemic levels in the United States, and finding adequate resources to fund future U.S. healthcare remains in question, the need for an already existing "boots on the ground" group that can address the disease is greater than ever.
0 comments - Aug 15, 2012 -
If you like cheese, there may be cause for celebration. According to a new study, eating cheese may lower your risk for type 2 diabetes
1 comment - Aug 8, 2012 -
Physically fit men with type 2 diabetes and a heart condition known as left ventricular hypertrophy run a considerably lower risk of premature death than their diabetic peers who are not fit. That's the conclusion of a longitudinal study of 866 patients conducted by Veterans Affairs Medical Center and George Washington University, Washington, DC.
0 comments - Aug 7, 2012 -
UC San Diego scientists have discovered a molecule involved in regulating the biological clock that could open a new path for treating type 2 diabetes. The molecule, dubbed KL001, controls a key protein, cryptochrome, that regulates the biological clock (circadian rhythm) in plants, animals, and humans. In doing so, cryptochrome indirectly affects the liver's production of glucose. KL001 can be manipulated to induce cryptochrome to slow the liver's glucose production, thus creating a possible new therapeutic approach to type 2 diabetes.
1 comment - Aug 6, 2012 -
A study has found that taking curcumin extract, the main ingredient of the popular Indian spice turmeric, may help ward off type 2 in those with prediabetes.
0 comments - Aug 4, 2012 -
Several hopeful trends emerged from this year's ADA Scientific Sessions in Philadelphia, held June 8 through 12.
1 comment - Jun 23, 2012 -
A clinical study has begun of a wearable device that continuously delivers basal insulin to people with type 2 diabetes. The device, PaQ®, is manufactured by CeQur SA, a Swiss company that has operations in Denmark and Massachusetts. Designed to provide three days of basal insulin delivery along with on-demand bolus insulin, the device incorporates a disposable insulin infuser reservoir attached to a reusable insulin monitor.
6 comments - Jun 16, 2012 -
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia